Search - tctmd.com

Displaying 41 - 60 of 405

Sort: Relevancy | Date

Presentation TCT 2016

Iatrogenic ASD After Transeptal Interventions: Frequency, Impact, and Treatment (If Any)

Presenter: Lee N. Benson, Ziyad M. Hijazi, David R. Holmes Jr.

November 01, 2016

Presentation TCT 2016

Imaging for Tanscatheter Mitral Valve Interventions

Presenter: Stephen H. Little, G. Burkhard Mackensen, Paul A. Grayburn

November 01, 2016

Presentation TCT 2016

Technical and Clinical Considerations of ASD Closure in the Elderly

Presenter: Lee N. Benson, Ziyad M. Hijazi, Damien P. Kenny

November 01, 2016

Presentation TCT 2016

Future TAVR Devices and Adjunctive Therapies

Presenter: Blase A. Carabello, George D. Dangas

November 01, 2016

Presentation TCT 2016

TAVR: Current Status of Devices and Indications

Presenter: Blase A. Carabello, George D. Dangas, Vinod H. Thourani

November 01, 2016

Presentation TCT 2016

From Pre-Clinical to Post-Approval: The Essential Role of Imaging

Presenter: Stephen H. Little, G. Burkhard Mackensen, Neil J. Weissman

November 01, 2016

Presentation TCT 2016

Echocardiographic Assessment of the Atrial Septum

Presenter: Lee N. Benson, Ziyad M. Hijazi, Craig E Fleishman

November 01, 2016

Presentation TCT 2016

Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Jai-Wun Park

November 01, 2016

Presentation TCT 2016

Can CT Help to Select LAA Closure Devices?

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Swaminatha V Gurudevan

November 01, 2016

Presentation TCT 2016

Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!)

Presenter: Andreas Baumbach, David Hildick-Smith, Ted Feldman

November 01, 2016

Presentation TCT 2016

Criteria to Select Candidates for Transcatheter Tricuspid Valve Interventions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min

November 01, 2016

Presentation TCT 2016

Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min

November 01, 2016

Presentation TCT 2016

Planning and Performing TAVR in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta

November 01, 2016

Presentation TCT 2016

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Comprehensive CT Algorithm Before TAVR

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, João L Cavalcante

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

News Industry News

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

November 01, 2016

Advertisement

Iatrogenic ASD After Transeptal Interventions: Frequency, Impact, and Treatment (If Any)

Imaging for Tanscatheter Mitral Valve Interventions

Technical and Clinical Considerations of ASD Closure in the Elderly

Future TAVR Devices and Adjunctive Therapies

TAVR: Current Status of Devices and Indications

From Pre-Clinical to Post-Approval: The Essential Role of Imaging

Echocardiographic Assessment of the Atrial Septum

Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients!

Can CT Help to Select LAA Closure Devices?

Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!)

Criteria to Select Candidates for Transcatheter Tricuspid Valve Interventions

Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions

Planning and Performing TAVR in the Patient With CKD

Post-TAVR Valve Thickening: Current Data and Open Questions

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Comprehensive CT Algorithm Before TAVR

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content